[:us]In the study, EPR-Mediated Tumor Targeting using Ultrasmall-hybrid Nanoparticles: From Animal to Human with Theranostic AGuIX Nanoparticles, SARRP was used to experience the therapeutic action of enhanced permeability and retention (EPR)-mediated tumor targeting using AGuIX® NPs at low dose specifically when accumulated and activated at the tumor site.
See more below, or the full study here.
[:]
Contact Us
Accurate dosimetry and reporting is the best practice in radiation research. While systems like the Xstrahl CIX series have been established as both reproducible and accurate, determining the exact dose delivered to a subject can be difficult due to the interactions...
Xstrahl in Action Researchers developed guidance on how and what to report in regard to dosimetry in radiation research.Publication Minimum reporting standards should be expected for preclinical radiobiology irradiators and dosimetryAuthors François Trompier, Larry A....
Xstrahl in Action A recent study aimed to characterize a detection system based on inorganic scintillators and determine its suitability for dosimetry in preclinical radiation research, using our Small Animal Radiation Research Platform (SARRP).Publication...
